| Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults (NCT05875961) | Seqirus | 2023-06-15 |
| Comparison Between Bupivacaine and Bupivacaine- Dexamethasone QLB for Postoperative Analgesia (NCT05918796) | Ain Shams University | 2023-06-15 |
| i-BiSSkApp for Swallowing Rehabilitation in Parkinson's Disease (NCT05837520) | University of South Florida | 2023-06-15 |
| The Efface of Ketamine vs. Magnesium Sulphate in the Management of Pain After Laparoscopic Cholecystectomy (NCT07248358) | Liaquat National Hospital & Medical College | 2023-06-15 |
| Effect of Nivolumab vs Placebo in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial (NCT05887830) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-06-15 |
| 64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT) (NCT05633160) | Clarity Pharmaceuticals Ltd | 2023-06-15 |
| Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients (NCT05616793) | Opus Genetics, Inc | 2023-06-15 |
| A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments (NCT05714839) | GlaxoSmithKline | 2023-06-14 |
| Single Dose Study of MK-2060 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Older Japanese Participants on Dialysis (MK-2060-012) (NCT05769595) | Merck Sharp & Dohme LLC | 2023-06-14 |
| A Multiple-Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of HS-10383 (NCT06092983) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2023-06-14 |
| Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis (NCT06175338) | Mabscale, LLC | 2023-06-14 |
| SHR1701 Alone or in Combination With SHR2554 in Relapsed or Refractory Classical Hodgkin Lymphoma (NCT05896046) | Chinese PLA General Hospital | 2023-06-14 |
| A Study to Assess the Effect of Phenytoin on the Drug Levels of Afimetoran and the Effect of Afimetoran on the Drug Levels of Midazolam (NCT05901714) | Bristol-Myers Squibb | 2023-06-14 |
| Vebreltinib Plus PLB1004 in EGFR-mutated, Advanced NSCLC With MET Amplification or MET Overexpression Following EGFR-TKI (NCT06343064) | Avistone Biotechnology Co., Ltd. | 2023-06-13 |
| Ascending Single-Dose and Multiple-Dose Study to Evaluate RJ4287 in Healthy Subjects (NCT05921006) | Nanjing Ruijie Pharma Co., Ltd. | 2023-06-13 |
| Study of Subcutaneously Administered ENT-03 for the Treatment of Obesity and Diabetes (NCT05925920) | Metabolics Pharma | 2023-06-13 |
| Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II (NCT05702463) | Montreal Heart Institute | 2023-06-13 |
| A Clinical Trial of TQC2938 Injection in Healthy Adult Subjects (NCT06449859) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2023-06-13 |
| A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia (NCT05865535) | AVEO Pharmaceuticals, Inc. | 2023-06-13 |
| A Study of LY3502970 in Participants With Impaired and Normal Liver Function (NCT05882032) | Eli Lilly and Company | 2023-06-13 |
| Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors (NCT05800964) | Amgen | 2023-06-13 |
| A Study of FZ-AD004 in Patients With Advanced Solid Tumors (NCT05914545) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2023-06-12 |
| A Study of LY3532226 in Participants With Type 1 Diabetes Mellitus (NCT05887999) | Eli Lilly and Company | 2023-06-12 |
| Phase 1 Study of HT-102 Administered Subcustaneously in Healthy Participants and Patients with Chronic Hepatitis B for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity (only in Participants with Chronic HBV Infection) (NCT06744686) | Suzhou HepaThera Biotech Co., Ltd. | 2023-06-12 |
| Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy (NCT05169060) | University of Iowa | 2023-06-12 |
| A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD) (NCT05919693) | EyeBiotech Ltd. | 2023-06-12 |
| A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis. (NCT05874622) | Jiangsu vcare pharmaceutical technology co., LTD | 2023-06-12 |
| Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis (NCT05835895) | Genascence Corporation | 2023-06-12 |
| A Study to Understand How the Study Medicine Called ARV-471 is Processed in Healthy Adults (NCT05930925) | Pfizer | 2023-06-12 |
| A Study to Evaluate XTR006 in Chinese Volunteers (NCT06151795) | Sinotau Pharmaceutical Group | 2023-06-12 |
| CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer (NCT05685602) | National Cancer Institute (NCI) | 2023-06-12 |
| A Study to Evaluate Pharmacokinetics (PK) and Safety of Inaxaplin in Participants With Renal Impairment (NCT05865171) | Vertex Pharmaceuticals Incorporated | 2023-06-12 |
| Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors (NCT05887492) | Tango Therapeutics, Inc. | 2023-06-12 |
| Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer (NCT05491083) | National University Hospital, Singapore | 2023-06-12 |
| Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's Syndrome (NCT07350707) | Peking Union Medical College Hospital | 2023-06-12 |
| A Phase 1 Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3167 Single Injection in Healthy Subjects and Patients With Type 2 Diabetes (NCT05996380) | Jiangsu HengRui Medicine Co., Ltd. | 2023-06-09 |
| A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers Co-administered the Medicine Rosuvastatin (NCT05898672) | Pfizer | 2023-06-09 |
| A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors (NCT05740956) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2023-06-09 |
| A Phase I/IIa Clinical Study to Assess the Single and Multiple Ascending Doses of MDR-001 Tablets in Healthy Participants and Obese/ Overweight Participants (NCT06778850) | MindRank AI Ltd | 2023-06-09 |
| Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies (NCT05753501) | AbbVie | 2023-06-09 |
| Study of LP-184 in Patients With Advanced Solid Tumors (NCT05933265) | Lantern Pharma Inc. | 2023-06-09 |
| ASC - Autism Study (NCT05602116) | Cell to Cure ApS | 2023-06-09 |
| Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors (NCT05681000) | Biostar Pharma, Inc. | 2023-06-09 |
| Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia (NCT05864885) | Aneira Pharma, Inc. | 2023-06-09 |
| Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors (NCT05700084) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2023-06-09 |
| The Effect of Food on the Pharmacokinetics (PK) of Emraclidine in Healthy Adult Participants (NCT05915546) | Cerevel Therapeutics, LLC | 2023-06-08 |
| Safety and Gut Microbiota Analysis of an Oral Microbiotherapy in Patients With Amyotrophic Lateral Sclerosis (NCT05889572) | MaaT Pharma | 2023-06-08 |
| Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis (NCT05887843) | Sandoz | 2023-06-08 |
| Bioequivalence Study of Rivaroxaban 10 mg Film-coated Tablets (NCT06558058) | Dexa Medica Group | 2023-06-08 |
| Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma (NCT05618366) | Weill Medical College of Cornell University | 2023-06-07 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Intravenous Administration of IRX-010 in Healthy Participants (NCT06356259) | ImmunoRx Pharma Inc. | 2023-06-07 |
| A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer (NCT05839600) | Boehringer Ingelheim | 2023-06-07 |
| A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy Participants (NCT05894928) | Eli Lilly and Company | 2023-06-07 |
| A Study of DS-7011a in Patients With Systemic Lupus Erythematosus (NCT05638802) | Daiichi Sankyo | 2023-06-07 |
| LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma (NCT05876715) | ERLINDA M GORDON | 2023-06-07 |
| A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Loss of Liver Function to Healthy Participants. (NCT05857644) | Pfizer | 2023-06-07 |
| Vedicitumomab Alone or in Combination for the Treatment of Locally Advanced or Metastatic SDC (NCT05898373) | Peking Union Medical College | 2023-06-07 |
| RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer (NCT05256745) | Georgetown University | 2023-06-06 |
| Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease (NCT05762952) | University of Virginia | 2023-06-06 |
| CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma (NCT05627323) | Chimeric Therapeutics | 2023-06-06 |
| Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET) (NCT05881135) | Ohio State University | 2023-06-06 |
| TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers (NCT05894421) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-06-06 |
| A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors (NCT05888831) | Bristol-Myers Squibb | 2023-06-06 |
| Posterior-line Treatment With Disitamab Vedotin Plus PD-1 in Advanced HER2-low Expressing Gastric Cancer (NCT06078982) | Shanghai East Hospital | 2023-06-06 |
| Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide (NCT05768035) | Smart Immune SAS | 2023-06-06 |
| A Study to Evaluate the Drug-drug Interaction of BMS-986196 With Oral Contraceptives in Healthy Female Participants (NCT05891262) | Bristol-Myers Squibb | 2023-06-06 |
| A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors (NCT05948865) | Conjupro Biotherapeutics, Inc. | 2023-06-06 |
| Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors (NCT06302062) | Guangzhou FineImmune Biotechnology Co., LTD. | 2023-06-06 |
| A Study to Compare Two Dosing Regimens for a New Malaria Vaccine (NCT06141057) | University of Oxford | 2023-06-06 |
| Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of FTL001 (NCT06410092) | Sound Biopharmaceuticals Ltd. | 2023-06-05 |
| A Study of [14C]-LY3537982 in Healthy Participants (NCT05901311) | Eli Lilly and Company | 2023-06-05 |
| A Study to Assess the Effects of Epetraborole on the QT Interval in Healthy Adult Subjects (NCT05995444) | AN2 Therapeutics, Inc | 2023-06-05 |
| Diabetic Neuropathic Pain Relief, 6 Weeks Dosage Sublingual Water-soluble CBD/PEA (NCT05766969) | Pure Green Pharmaceuticals Inc. | 2023-06-05 |
| FUS Etoposide for DMG (NCT05762419) | Columbia University | 2023-06-05 |
| A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy (NCT05879523) | Shandong Suncadia Medicine Co., Ltd. | 2023-06-05 |
| A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors (NCT05848739) | Sapience Therapeutics | 2023-06-05 |
| Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors (NCT05797168) | AstraZeneca | 2023-06-05 |
| Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD) (NCT05443464) | Ossium Health, Inc. | 2023-06-05 |
| Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids (NCT05123040) | Masonic Cancer Center, University of Minnesota | 2023-06-05 |
| Vitamin B12 Dose Escalation Trial in Pregnancy (NCT05426395) | George Washington University | 2023-06-05 |
| First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer (NCT05141149) | Prestige Biopharma Limited | 2023-06-05 |
| A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors (NCT05867303) | RemeGen Co., Ltd. | 2023-06-05 |
| A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies (NCT05908409) | IDP Discovery Pharma S.L. | 2023-06-05 |
| CT-guided Percutaneous Radionuclide Therapy With 32P Microparticles in Patients With Non-progressive Locally Advanced Pancreatic Cancer (NCT07595835) | M.R. Meijerink | 2023-06-04 |
| A Study to Learn About the Study Medicine PF-07853578 and How it Acts in the Bodies of Healthy Adults (NCT05890105) | Pfizer | 2023-06-02 |
| Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model in Head and Neck Cancer (NCT05621889) | Centre hospitalier de l'Université de Montréal (CHUM) | 2023-06-02 |
| Evaluation of the Safety and Efficacy of Infantile-onset Pompe Disease Gene Therapy Drug (NCT05793307) | GeneCradle Inc | 2023-06-02 |
| Bioequivalence of Amphotericin B Liposome for Injection (NCT05913921) | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 2023-06-02 |
| Study to Evaluate the Safety and Pharmacokinetics of CKD-379 (NCT05952219) | Chong Kun Dang Pharmaceutical | 2023-06-02 |
| A Study to Assess the Effects of Fluvoxamine on Savolitinib Exposure in Healthy Male Subjects (NCT05888207) | AstraZeneca | 2023-06-02 |
| A Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers (NCT05993806) | Celltrion | 2023-06-02 |
| Ketone Pharmacokinetic Study in HFrEF (NCT05757193) | Duke University | 2023-06-02 |
| Investigating The Effects Of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) On Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) (NCT06621888) | Fenix Innovation Group | 2023-06-02 |
| CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer (NCT05187182) | Washington University School of Medicine | 2023-06-02 |
| The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors (NCT05967533) | University of California, Davis | 2023-06-02 |
| COMP-4 Supplementation and Brachial Artery FMD (NCT05595915) | University of California, Los Angeles | 2023-06-01 |
| Allopurinol and Pathogenesis of Cirrhosis (NCT07033533) | Tanta University | 2023-06-01 |
| Neoantigen Derived DCs as Cancer Treatment (NCT05767684) | National Health Research Institutes, Taiwan | 2023-06-01 |
| CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC (NCT05774899) | Glenn J. Hanna | 2023-06-01 |
| A Family Dyad-focused Diabetes Self-Management Intervention for African American Adults (NCT05905575) | Ohio State University | 2023-06-01 |